SCHEMBL8765150

SCHEMBL8765150

CC(=O)NCc1ccc(-c2c(C(F)F)nn(-c3ccccc3)c2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.46
CA1 P00915 10/20 0.44
CA2 P00918 10/20 0.44
CA7 P43166 5/20 0.44
CA9 Q16790 5/20 0.44
CA12 O43570 4/20 0.44
CA5A P35218 2/20 0.44
CA5B Q9Y2D0 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 2/20 0.43
PTGS1 P23219 2/20 0.42
LMNA P02545 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8764774 0.97 PTGS2 (0.49) PTGS2CA1CA2CA7CA9
SCHEMBL8765404 0.95 PTGS2 (0.43) PTGS2CA1CA2CA7CA9
SCHEMBL8765529 0.92 PTGS2 (0.41) PTGS2KDM4E
SCHEMBL8765120 0.89 EPHX2 (0.42) PTGS2
SCHEMBL8764467 0.87 CCR1 (0.43) PTGS2
SCHEMBL8764490 0.86 CA1 (0.48) PTGS2CA1CA2CA7CA9
SCHEMBL8764505 0.86 PTGS2 (0.49) PTGS2CA1CA2CA9PTGS1
SCHEMBL8632941 0.85 PTGS2 (0.55) PTGS2CA1CA2CA7CA9
Dimethylamine SCHEMBL8765256 0.84 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL8765086 0.84 PTGS2 (0.54) PTGS2CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed